A Comparison of Criteria to Identify Inflammatory Breast Cancer Cases from Medical Records and the Surveillance, Epidemiology and End Results Data base, 2007–2009
dc.contributor.author | Hirko, Kelly A. | en_US |
dc.contributor.author | Soliman, Amr S. | en_US |
dc.contributor.author | Banerjee, Mousumi | en_US |
dc.contributor.author | Ruterbusch, Julie | en_US |
dc.contributor.author | Harford, Joe B. | en_US |
dc.contributor.author | Merajver, Sofia D. | en_US |
dc.contributor.author | Schwartz, Kendra | en_US |
dc.date.accessioned | 2014-05-21T18:02:30Z | |
dc.date.available | 2015-06-01T15:48:43Z | en_US |
dc.date.issued | 2014-03 | en_US |
dc.identifier.citation | Hirko, Kelly A.; Soliman, Amr S.; Banerjee, Mousumi; Ruterbusch, Julie; Harford, Joe B.; Merajver, Sofia D.; Schwartz, Kendra (2014). "A Comparison of Criteria to Identify Inflammatory Breast Cancer Cases from Medical Records and the Surveillance, Epidemiology and End Results Data base, 2007–2009." The Breast Journal 20(2): 185-191. | en_US |
dc.identifier.issn | 1075-122X | en_US |
dc.identifier.issn | 1524-4741 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/106657 | |
dc.description.abstract | Inflammatory breast cancer ( IBC ) is a relatively rare and extremely aggressive form of breast cancer that is diagnosed clinically. Standardization of clinical diagnoses is challenging, both nationally and internationally; moreover, IBC coding definitions used by registries have changed over time. This study aimed to compare diagnostic factors of IBC reported in a U.S. Surveillance, Epidemiology, and End Results ( SEER ) registry to clinical criteria found in the medical records of all invasive breast cancer cases at a single institution. We conducted a medical record review of all female invasive breast cancers ( n = 915) seen at an NCI‐designated comprehensive cancer center in Detroit from 2007 to 2009. IBC cases were identified based on the presence of the main clinical characteristics of the disease (erythema, edema, peau d'orange). We compared the proportion of IBC out of all breast cancers, using these clinical criteria and the standard SEER IBC codes. In the reviewed cases, the clinical criteria identified significantly more IBC cases ( n = 74, 8.1%) than the standard IBC SEER definition ( n = 19, 2.1%; p < 0.0001). No IBC cases were identified in the cancer center records using the SEER pathologic coding, which requires the diagnosis of inflammatory carcinoma on the pathology report, a notation that is rarely made. Emphasis must be placed on the documentation of clinical and pathologic characteristics of IBC in the medical record, so that analysis of putative IBC subtypes will be possible. Our results indicate the need for a consensus on the definition of IBC to be utilized in future research. | en_US |
dc.publisher | Woods's Medical and Surgical Monographs | en_US |
dc.publisher | Wiley Periodicals, Inc. | en_US |
dc.subject.other | Diagnostic Criteria | en_US |
dc.subject.other | SEER | en_US |
dc.subject.other | Inflammatory Breast Cancer | en_US |
dc.title | A Comparison of Criteria to Identify Inflammatory Breast Cancer Cases from Medical Records and the Surveillance, Epidemiology and End Results Data base, 2007–2009 | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Obstetrics and Gynecology | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/106657/1/tbj12234.pdf | |
dc.identifier.doi | 10.1111/tbj.12234 | en_US |
dc.identifier.source | The Breast Journal | en_US |
dc.identifier.citedreference | Soliman AS, Banerjee M, Lo AC, et al. High proportion of inflammatory breast cancer in the population‐based cancer registry of Gharbiah, Egypt. Breast J 2009; 15: 432 – 4. | en_US |
dc.identifier.citedreference | Woodward WA, Cristofanilli M. Inflammatory breast cancer. Semin Radiat Oncol 2009; 19: 256 – 65. | en_US |
dc.identifier.citedreference | Merajver SD, Goodman VL, Sabel MS. Inflammatory breast cancer: advances in molecular genetics and treatment. In: Bonadonna G, Hortobagyi GN, Valagussa P, eds. Textbook of Breast Cancer: A Clinical Guide to Therapy, 3rd edn. London: Taylor & Francis, 2006: 241 – 56. | en_US |
dc.identifier.citedreference | Merajver SD, Iniesta MD, Sabel MS. Inflammatory Breast Cancer, Chapter 62. In: Harris JR, Lippman ME, Morrow M, Osborne CK, eds. Diseases of the Breast, 4th edn. Philadelphia, PA: Lippincott Williams & Wilkins, 2010: 762 – 73. | en_US |
dc.identifier.citedreference | Chang S, Parker SL, Pham T, Buzdar MD, Hursting SD. Inflammatory breast cancer incidence and survival: the Surveillance Epidemiology and End Results program of the National Cancer Institute, 1975–1992. Cancer 1998; 82: 2366 – 72. | en_US |
dc.identifier.citedreference | SEER. ICD‐O‐3 Coding Materials. 2004. Available at: http://seer.cancer.gov/icd-o-3/. | en_US |
dc.identifier.citedreference | SEER. Available at: http://seer.cancer.gov/tools/mphrules/ | en_US |
dc.identifier.citedreference | Greene FL, Page DL, Fritz A, Balch CM, Haller DG, Morrow M. Breast, in AJCC Cancer Staging Manual, 6th edn. New York, NY: Springer‐Verlag, 2002: 255 – 81. | en_US |
dc.identifier.citedreference | Surveillance Epidemiology and End Results Program. SEER research record description: cases diagnosed in 1973–2007, November 2009 data submission. Bethesda, MD: National Cancer Institute. Available at: http://seer.cancer.gov/manuals/2010/appendixc.html (accessed September 9, 2012). | en_US |
dc.identifier.citedreference | Schlichting JA, Soliman AS, Schairer C, et al. Association of inflammatory and noninflammatory breast cancer with socioeconomic characteristics in the surveillance, epidemiology, and end results database, 2000–2007. Cancer Epidemiol Biomarkers Prev 2012; 21: 155 – 65. | en_US |
dc.identifier.citedreference | Schairer C, Brown LM, Mai PL. Inflammatory breast cancer: high risk of contralateral breast cancer compared to comparably staged non‐inflammatory breast cancer. Breast Cancer Res Treat 2011; 129: 117 – 24. | en_US |
dc.identifier.citedreference | Levine PH, Steinhorn SC, Ries LG, Aron JL. Inflammatory breast cancer. The experience of the Surveillance, Epidemiology and End Results (SEER) Program. J Natl Cancer Inst 1985; 74: 291 – 7. | en_US |
dc.identifier.citedreference | Hance KW, Anderson WF, Devesa SS, Young HA, Levine PH. Trends in inflammatory breast carcinoma incidence and survival: the Surveillance, Epidemiology, and End Results program at the National Cancer Institute. J Natl Cancer Inst 2005; 97: 966 – 75. | en_US |
dc.identifier.citedreference | Anderson WF, Schairer C, Chen BE, Hance KW, Levine PH. Epidemiology of inflammatory breast cancer. Breast Dis 2005 ‐2006; 22: 9 – 23. | en_US |
dc.identifier.citedreference | Mourali N, Muenz L, Tabbane F, Belhassen S, Bahi J, Levine PH. Epidemiologic features of rapidly progressing breast cancer in Tunisia. Cancer 1980; 46: 2741 – 6. | en_US |
dc.identifier.citedreference | Boussen H, Bouzaiene H, Hassouna JB, Gamoudi A, Benna F, Rahal K. Inflammatory breast cancer in Tunisia: reassessment of incidence and clinicopathological features. Semin Oncol 2008; 35: 17 – 24. | en_US |
dc.identifier.citedreference | Omar S, Khaled H, Gaafar R. Breast cancer in Egypt: a review of disease presentation and detection strategies. East Mediterr Health J 2003; 9: 448 – 63. | en_US |
dc.identifier.citedreference | Dawood S, Cristofanilli M. What progress have we made in managing inflammatory breast cancer? Oncology (Williston Park) 2007; 21: 673 – 9. | en_US |
dc.identifier.citedreference | Ellis DL, Teitelbaum SL. Inflammatory carcinoma of the breast. A pathologic definition. Cancer 1974; 33: 1045 – 7. | en_US |
dc.identifier.citedreference | Saltzstein SL. Clinically occult inflammatory carcinoma of the breast. Cancer 1974; 34: 382 – 8. | en_US |
dc.identifier.citedreference | Levine PH, Venerose C. The epidemiology of inflammatory breast cancer. Semin Oncol 2008; 35: 11 – 6. | en_US |
dc.identifier.citedreference | Taylor SH, Walters R. Potential impact of tumor registry rule changes for recording inflammatory breast cancer. Cancer 2010; 116 ( 11 suppl ): 2745 – 7. | en_US |
dc.identifier.citedreference | Fields JN, Kuske RR, Perez CA, Fineberg BB, Bartlett N. Prognostic factors in inflammatory breast cancer. Univariate and multivariate analysis. Cancer 1989; 63: 1225 – 32. | en_US |
dc.identifier.citedreference | Kim T, Lau J, Erban J. Lack of uniform diagnostic criteria for inflammatory breast cancer limits interpretation of treatment outcomes: a systematic review. Clin Breast Cancer 2006; 7: 386 – 95. | en_US |
dc.identifier.citedreference | Cristofanilli M, Bucholz TA. Proceedings of the first international inflammatory breast cancer conference. Cancer 2010; 116 ( 11 Suppl ): 2729. | en_US |
dc.identifier.citedreference | Anderson WF, Chu KC, Chang S. Inflammatory breast carcinoma and non‐inflammatory locally advanced breast carcinoma: distinct clinicopathologic entities. J Clin Oncol 2003; 21: 2254 – 9. | en_US |
dc.identifier.citedreference | Overmeyer BA. Inflammatory breast cancer: novel preoperative therapies. Clin Breast Cancer 2010; 10: 27 – 32. | en_US |
dc.identifier.citedreference | Bryant T. Disease of the Breast, vol. 4. New York: Woods's Medical and Surgical Monographs, 1889: 35 – 322. | en_US |
dc.identifier.citedreference | Rowan K. Inflammatory breast cancer: new hopes and many hurdles. J Natl Cancer Inst 2009; 101: 1302 – 4. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.